38 related articles for article (PubMed ID: 38499006)
1. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
[TBL] [Abstract][Full Text] [Related]
2. The 2023 Bethesda System for reporting thyroid cytopathology.
Ali SZ; Baloch ZW; Cochand-Priollet B; Schmitt FC; Vielh P; VanderLaan PA
J Am Soc Cytopathol; 2023; 12(5):319-325. PubMed ID: 37438235
[TBL] [Abstract][Full Text] [Related]
3. The 2023 Bethesda System for Reporting Thyroid Cytopathology.
Ali SZ; Baloch ZW; Cochand-Priollet B; Schmitt FC; Vielh P; VanderLaan PA
Thyroid; 2023 Sep; 33(9):1039-1044. PubMed ID: 37427847
[TBL] [Abstract][Full Text] [Related]
4. The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel.
Pusztaszeri M; Rossi ED; Auger M; Baloch Z; Bishop J; Bongiovanni M; Chandra A; Cochand-Priollet B; Fadda G; Hirokawa M; Hong S; Kakudo K; Krane JF; Nayar R; Parangi S; Schmitt F; Faquin WC
J Am Soc Cytopathol; 2016; 5(5):245-251. PubMed ID: 31042501
[TBL] [Abstract][Full Text] [Related]
5. What's new in thyroid pathology 2024: updates from the new WHO classification and Bethesda system.
Bychkov A; Jung CK
J Pathol Transl Med; 2024 Mar; 58(2):98-101. PubMed ID: 38499006
[TBL] [Abstract][Full Text] [Related]
6. The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology.
Rossi ED; Baloch Z
Endocr Pathol; 2023 Mar; 34(1):23-33. PubMed ID: 36797454
[TBL] [Abstract][Full Text] [Related]
7. The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel.
Pusztaszeri M; Rossi ED; Auger M; Baloch Z; Bishop J; Bongiovanni M; Chandra A; Cochand-Priollet B; Fadda G; Hirokawa M; Hong S; Kakudo K; Krane JF; Nayar R; Parangi S; Schmitt F; Faquin WC
Acta Cytol; 2016; 60(5):399-405. PubMed ID: 27764825
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
9. The 5
Basolo F; Macerola E; Poma AM; Torregrossa L
Endocrine; 2023 Jun; 80(3):470-476. PubMed ID: 36964880
[TBL] [Abstract][Full Text] [Related]
10. The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to look-ahead.
Baloch Z; LiVolsi VA
Diagn Cytopathol; 2020 Oct; 48(10):862-866. PubMed ID: 31999070
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
